MedTrace Logo

Tendyne European Experience Registry

NCT04898335 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-05-24

No results posted yet for this study

Summary

TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

Tendyne Mitral Valve System

Tendyne Mitral Valve System for mitral valve disease in a commercial setting

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Joerg Hausleiter, MD · LMU Klinikum Munich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2026-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Italy
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04898335 on ClinicalTrials.gov